Defining Optimum Cup Orientation for Hip Replacements Taking Into Account the Individual's Anatomy and Movement Patterns

Sponsor
Ottawa Hospital Research Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT04633525
Collaborator
(none)
400
1
1
37.4
10.7

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate and determine the optimal zone for implanting the cup component (the ball that sits in the joint socket) in a total hip replacement. Enrolled participants will have a series of X-rays analyzed before surgery to identify their individual optimal zone or cup orientation. This information will be provided to the operating surgeon, who may use this information to influence the placement of the cup implant. Follow-up X-rays taken after surgery will determine if the cup is within the suggested optimal zone. Questionnaires will be completed before and after surgery, and data on complications or issues with the surgery (including incidents of dislocation) will be collected after surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Optimum Cup Orientation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Prospective Study to Define Optimum Cup Orientation in Hip Arthroplasty Accounting for the Individual's Anatomy and Movement Patterns
Actual Study Start Date :
Nov 18, 2020
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Optimum Cup Orientation

Procedure: Optimum Cup Orientation
Participants will have X-rays taken before surgery to determine the target optimal zone for orientation of the cup implant, using EBRA software. The surgeon may or may not implant in this target zone, depending on what they believe is in the patient's best interest. X-rays will be taken at 12 months after surgery to determine if they target cup orientation was achieved.

Outcome Measures

Primary Outcome Measures

  1. Cup Orientation [12 months after surgery]

    The degree of cup inclination and anteversion as shown on X-rays

Secondary Outcome Measures

  1. Change in Patient Reported Function [12 months]

    Assess the change in function using the Oxford Hip Score. Total scores range from 0-48. The higher the score, the better the outcome.

  2. Change in Patient Reported Pain [12 months]

    Assess the change in pain using the Oxford Hip Score. Total scores range from 0-48. The higher the score, the better the outcome.

  3. Change in Patient Reported Health [12 months]

    Assess the change in general health using the EQ-5D-5L

  4. Change in Patient Reported Health [12 months]

    Assess the change in general health using the PROMIS-15

  5. Incidence of Adverse Events [Up to 12 months after surgery]

    Assess safety and post-operative complications by collecting information on adverse events and serious adverse events

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Signed up for primary total hip arthroplasty procedures at the General Campus at The Ottawa Hospital.
Exclusion Criteria:
  • Unwilling or unable to complete study requirements (either X-rays or questionnaires)

  • Unwilling or unable to sign the informed consent form

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Ottawa Hospital Ottawa Ontario Canada K1H 8L6

Sponsors and Collaborators

  • Ottawa Hospital Research Institute

Investigators

  • Principal Investigator: George Grammatopoulos, Ottawa Hospital Research Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT04633525
Other Study ID Numbers:
  • 2251
First Posted:
Nov 18, 2020
Last Update Posted:
Feb 24, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ottawa Hospital Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2021